Atlas Trials

Study of Immune Tolerance and Capacity for Wound Healing of Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB)

Clinical trial NCT01874769 · COMPLETED

Trial details

NCT number
NCT01874769
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Status
COMPLETED
Study type
OBSERVATIONAL
Recessive Dystrophic Epidermolysis Bullosa
Start date
2013-08-01
Primary completion
2017-08-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.